Discovery of another mechanism for the inhibition of particulate guanylyl cyclases by the natriuretic peptide clearance receptor
Proceedings of the National Academy of Sciences · 2023
DOI: 10.1073/pnas.2307882120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Dianxin Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville TN 37232. Hauptthemen laut MEDLINE: Guanylate Cyclase, Receptors, Atrial Natriuretic Factor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NCI NIH HHS, American Heart Association.
Abstract (Originalsprache)
The cardiac natriuretic peptides (NPs) control pivotal physiological actions such as fluid and electrolyte balance, cardiovascular homeostasis, and adipose tissue metabolism by activating their receptor enzymes [natriuretic peptide receptor-A (NPRA) and natriuretic peptide receptor-B (NPRB)]. These receptors are homodimers that generate intracellular cyclic guanosine monophosphate (cGMP). The natriuretic peptide receptor-C (NPRC), nicknamed the clearance receptor, lacks a guanylyl cyclase domain; instead, it can bind the NPs to internalize and degrade them. The conventional paradigm is that by competing for and internalizing NPs, NPRC blunts the ability of NPs to signal through NPRA and NPRB. Here we show another previously unknown mechanism by which NPRC can interfere with the cGMP signaling function of the NP receptors. By forming a heterodimer with monomeric NPRA or NPRB, NPRC can prevent the formation of a functional guanylyl cyclase domain and thereby suppress cGMP production in a cell-autonomous manner.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville TN 37232.
- Integrative Metabolism Program, Sanford Burnham Prebys Medical Discovery Institute, Orlando, FL 32827.
- Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37232.
ORCID-Profile: Ryan P Ceddia, Sheila Collins
Förderung
- NIDDK NIH HHS
- NCI NIH HHS
- American Heart Association
- HHS | National Institutes of Health
- American Diabetes Association
Zitieren
APA
Liu, D., Ceddia, R. P., Zhang, W., Shi, F., Fang, H., & Collins, S. (2023). Discovery of another mechanism for the inhibition of particulate guanylyl cyclases by the natriuretic peptide clearance receptor. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2307882120
Vancouver
Liu D, Ceddia RP, Zhang W, Shi F, Fang H, Collins S. Discovery of another mechanism for the inhibition of particulate guanylyl cyclases by the natriuretic peptide clearance receptor. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2307882120
BibTeX
@article{Liu2023,
author = {Liu, Dianxin and Ceddia, Ryan P and Zhang, Wei and Shi, Fubiao and Fang, Huafeng and Collins, Sheila},
title = {Discovery of another mechanism for the inhibition of particulate guanylyl cyclases by the natriuretic peptide clearance receptor},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
doi = {10.1073/pnas.2307882120}
}
EUVIMED